2006 Fiscal Year Final Research Report Summary
Development of HIV-1 coreceptor-based HIV /AIDS defense vaccine
| Project/Area Number |
16390023
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
SHOJI Shozo Kumamoto University, Faculty of Medical and Pharmaceutical Science, Ph.D., Professor, 大学院医学薬学研究部, 教授 (60040317)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
MISUMI Shogo Kumamoto University, Faculty of Medical and Pharmaceutical Science, Ph.D., Professor, 大学院医学薬学研究部, 助教授 (40264311)
TAKAMUNE Nobutoki Kumamoto University, Faculty of Medical and Pharmaceutical Science, Ph.D., Professor, 大学院医学薬学研究部, 助手 (60322749)
|
|---|
| Project Period (FY) |
2004 – 2006
|
| Keywords | HIV-1 / Vaccine / Coreceptor / UPA |
|---|
| Research Abstract |
A cyclic chimeric dodecapeptide (cCD) mimicking the conformation-specific domains of CCR5 and CXCR4 was prepared in which Gly-Asplinkstheaminoandcarboxylterminioftwocombinedpentapeptides(S_<169>-G_<173> of CCR5 ; E_<179>-R_<183> of CXCR4) derived from human immunodeficiency virus type-1 (HIV-1) coreceptors. The immunization of Balb/c mice with cCD conjugated with a multiple-antigen peptide (cCD-MAP) induced seven cCD-specific monoclonal antibodies (mAbs, CPMAb-I to-VII) that reacted with native CCR5 and CXCR4. Among the tested mAbs, CPMAb-I and-II potently inhibited the infection of both the R5 and X4 laboratory strains. CPMAb-III and-V1wereeffectiveagainstonlyR5laboratorystrains, and also against some X4 and R5 primary isolates. CPMAb-IV and-Vhadpotent antiviral activities againsttheR5 and X4 primary isolates. In particular, CPMAb-VII was protective against not only R5 and X4 laboratory strains, but also most of the R5 and X4 primary isolates. Moreover, cCD-MAP immunization also induced antibodies that were effective against R5 and X4 multiclade HIV-1 isolates in vitro in two of three cynomolgus monkeys. Taken together, the results suggest that cCD-MAPisacandidatemulticladeimmunogenthatcanbeused to block multiclade R5 and X4 HIV-1 infections.
|
Research Products
(7 results)
-
[Journal Article] Effects of Immunization with CCR5-Based Cycloimmunoger on Simian/HIVSF_<162P3> Challenge.2006
Author(s)
Misumi S, Nakayama D, Kusaba, M, Iiboshi T, Mukai R, Tachibana K, Nakasone T, Umeda M, Shibats H, Endo M, Takamune N, Shoji S
-
Journal Title
J Immunol. 176
Pages: 463-471
Description
「研究成果報告書概要(和文)」より
-
-
[Journal Article] Effects of Immunization with CCR5-Based Cycloimmunogen on Simian/HIVSF162P3 Challenge.2006
Author(s)
Misumi S, Nakayama D, Kusaba M, liboshi T, Mukai R, Tachibana K, Nakasone T, Umeda M, Shibata H, Endo M, Takamune N, Shoji S.
-
Journal Title
J Immunol. 176
Pages: 463-471
Description
「研究成果報告書概要(欧文)」より
-
-
-
-
